Clinical Trial Update: Aripiprazole Augmentation of Antidepressants in PTSD [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating adding aripiprazole to antidepressants in patients with post-traumatic stress disorder have been completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Durham VA Medical Center | Conditions: PTSD | Phase 2 | Status: COMPLETED | Results posted: 2012-03-28